Zimmer Biomet (ZBH) PT Raised to $153 at Needham & Company; Buy on Weakness
Tweet Send to a Friend
Needham & Company raised its price target on Zimmer Biomet (NYSE: ZBH) to $153.00 (from $151.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
